Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-17-001988
Filing Date
2017-02-09
Accepted
2017-02-09 10:11:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 atrn20170207_424b3.htm 424B3 2267679
2 schulman.jpg GRAPHIC 376408
3 a1.jpg GRAPHIC 15754
  Complete submission text file 0001437749-17-001988.txt   2806653
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-213671 | Film No.: 17585227
SIC: 7389 Services-Business Services, NEC